AI assistant
Sending…
RESMED INC — Director's Dealing 2018
Dec 6, 2018
30071_dirs_2018-12-06_33c6f545-c391-4850-b216-0cabacec689c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2018-12-03
Reporting Person: PENDARVIS DAVID (Chief Administrative Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-12-03 | ResMed Common Stock | M | 4455 | $51.25 | Acquired | 122457 | Direct |
| 2018-12-03 | ResMed Common Stock | S | 4455 | $112.09 | Disposed | 118002 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-12-03 | ResMed Common Stock Options | $51.25 | M | 4455 | Disposed | 2020-11-13 | ResMed Common Stock (4455) | Direct |
Footnotes
F1: The transaction was conducted under a Rule 10b5-1 plan.
F2: Represents date options first became exercisable. Options vest 1/3 per year.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29